Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-035316
Filing Date
2011-06-06
Accepted
2011-06-06 20:57:51
Documents
1
Period of Report
2011-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd314634.html 4  
1 FORM 4 rrd314634.xml 4 3727
  Complete submission text file 0001181431-11-035316.txt   5150
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5118 HOLLY TERRACE HOUSTON TX 77056
Business Address
PRESSLER HERMAN PAUL (Reporting) CIK: 0001522481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 11896848